Fig. 1: Clinical measurements before and after Teprotumumab.
From: Teprotumumab for the treatment of chronic thyroid eye disease

a Changes in exophthalmometry, the CAS and Gorman diplopia scores before and after therapy. b Changes to gaze restriction for each of the rectus muscles before and after Teprotumumab therapy.